TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biomedola AB
Closing information (x1000 EUR)
| Closing information | 2025/12 | 2024/12 | 2023/12 |
| Turnover |
89
|
105 | |
| Financial expenses |
6
|
0 | |
| Earnings before taxes |
129
|
74 | |
| EBITDA |
43
|
70 | |
| Total assets |
538
|
455 | |
| Current assets |
348
|
279 | |
| Current liabilities |
17
|
19 | |
| Equity capital |
494
|
407 | |
| - share capital |
4
|
5 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Solvency |
91.8%
|
89.5% | |
| Turnover per employee |
89
|
105 | |
| Profit as a percentage of turnover |
144.9%
|
70.5% | |
| Return on assets (ROA) |
25.1%
|
16.3% | |
| Current ratio |
2047.1%
|
1468.4% | |
| Return on equity (ROE) |
26.1%
|
18.2% | |
| Change turnover |
-13
|
18 | |
| Change turnover % |
1%
|
-13%
|
21% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.